|Bid||175.58 x 800|
|Ask||197.70 x 900|
|Day's Range||184.67 - 189.09|
|52 Week Range||96.46 - 203.67|
|Beta (5Y Monthly)||1.23|
|PE Ratio (TTM)||31.96|
|Earnings Date||Aug 18, 2020 - Aug 24, 2020|
|Forward Dividend & Yield||1.52 (0.81%)|
|Ex-Dividend Date||May 22, 2020|
|1y Target Est||208.50|
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
Shares of manufacturer Nordson Corporation (NASDAQ: NDSN) rose 17.1% in May, according to data provided by S&P Global Market Intelligence. For the year to date, Nordson's shares are up 23.4%, compared to a flat S&P 500. It's a very specific niche market, although it does serve a wide variety of industries, including automotive, electronics, aerospace, and healthcare.
Nordson Corp. (NDSN) has bought Pennsylvania-based Fluortek, Inc., a plastic extrusion manufacturer to add medical tubing components to its product portfolio for complex medical devices.The financial terms of the deal weren’t disclosed. Flurotek, which provides custom dimensioned tubing to the medical device industry, will become part of the Nordson Medical product line within Nordson’s Advanced Technology Solutions segment.“As Nordson Medical continues to expand its differentiated product offerings, the acquisition of Fluortek enhances our ability to deliver critical components that enable our customers’ most complex medical device innovations,” said Nordson Executive VP Jeffrey Pembroke. “This offering further supports Nordson Medical’s position as a leading full-service solution provider of component and device manufacturing capabilities across the interventional, minimally invasive and surgical medical device landscape.”Shares in Nordson have seen their value almost double since March 23. The stock fell 1.6% to $185.36 as of Monday’s close. It was up 0.9% in Tuesday’s pre-market trading.DA Davidson analyst Matt Summerville last week raised the stock’s price target to $200 from $185 and maintained a Buy rating after Q2 earnings beat expectations.Nordson “has seen some order volatility in recent weeks, but its consumer non-durables and medical end markets are performing well, helping to offset more cyclically sensitive automotive, general industrial, and electronics markets,” Summerville wrote in a note to investors.Overall, most Wall Street analysts share Summerville’s bullish rating outlook. Out of 6 recent reviews, 5 boast Buys and 1 assigns a Hold adding up to a Strong Buy consensus. The $203 average price target indicates analysts see more modest upside potential of 9.5% in the coming 12 months. (See Nordson stock analysis on TipRanks).Related News: Google Mulling Purchase of Stake in Indian Vodafone Idea FB Holds ‘Productive’ Call With Trump, As Social Media War Rages On Microsoft Seeks $2B Stake In India’s Jio Platforms- Report More recent articles from Smarter Analyst: * Hertz Set To Challenge NYSE Delisting In Upcoming Hearing * Genmab Shares Rise 5% In Pre-Market On Oncology Partnership With AbbVie * Coupa Software Seeks To Raise $1.1 Billion From Debt Sale * Global Airlines Are Set To Lose $84.3 Billion In 2020, IATA Says
Nordson Corporation Acquires Fluortek, Inc., Expanding Medical Tubing Offerings for Complex Medical Devices
Nordson EFD, a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, introduces OptiSure™ Automated Optical Inspection (AOI) software and confocal laser as add-ons to its existing vision-guided dispensing robots.
Confluence Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below. The All Cap Value Fund posted a return of -22.4% for the quarter (net of fees), outperforming its benchmark, the Russell 3000 Value Index which returned -27.3% in the same quarter. You should check out Confluence Investment […]
Aoris Investment Management recently released its Q1 2020 Investor Letter, a copy of which you can download below. The Aoris International Fund aims to generate returns of 8–12% p.a. over a market cycle. The portfolio is long-only and highly selective. You should check out Aoris Investment Management’s top 5 stock picks for investors to buy right […]
Nordson's (NDSN) earnings in second-quarter fiscal 2020 benefited from lower costs and expenses, partially offsetting the sales decline. It withdrew fiscal 2020 view due to pandemic worries.
Nordson (NDSN) delivered earnings and revenue surprises of 23.44% and 4.13%, respectively, for the quarter ended April 2020. Do the numbers hold clues to what lies ahead for the stock?
Nordson (NDSN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nordson (NDSN) is poised to gain from strong medical end markets, growth initiatives and buyouts. Weak Advanced Technology Systems segment and high costs remain concerning.
Nordson Corporation Announces Earnings Release and Webcast for Second Quarter Fiscal Year 2020
Nordson EFD, a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, celebrates Earth Day by introducing a new line of sustainably-sourced Optimum® ECO dispensing components, including syringe barrels, pistons, end caps, and tip caps.
Nordson EFD, a Nordson company (NASDAQ: NDSN), the world’s leading precision fluid dispensing systems manufacturer, is dedicated to helping manufacturers increase production capacity to meet the growing demand for medical devices used to treat and test for symptoms of the novel coronavirus (SARS-CoV-2).